Logo image of CML.MI

COMAL SPA (CML.MI) Stock Fundamental Analysis

Europe - BIT:CML - IT0005428971 - Common Stock

5.08 EUR
0 (0%)
Last: 3/17/2025, 7:00:00 PM
Fundamental Rating

5

CML gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 61 industry peers in the Electrical Equipment industry. CML scores excellent on profitability, but there are concerns on its financial health. CML is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year CML was profitable.
In the past year CML has reported a negative cash flow from operations.
CML had positive earnings in each of the past 5 years.
In the past 5 years CML reported 4 times negative operating cash flow.
CML.MI Yearly Net Income VS EBIT VS OCF VS FCFCML.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

CML's Return On Assets of 1.83% is in line compared to the rest of the industry. CML outperforms 59.62% of its industry peers.
With an excellent Return On Equity value of 20.81%, CML belongs to the best of the industry, outperforming 90.38% of the companies in the same industry.
CML has a Return On Invested Capital of 14.56%. This is amongst the best in the industry. CML outperforms 94.23% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CML is in line with the industry average of 9.35%.
The last Return On Invested Capital (14.56%) for CML is above the 3 year average (10.49%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.83%
ROE 20.81%
ROIC 14.56%
ROA(3y)2.62%
ROA(5y)2.89%
ROE(3y)17.19%
ROE(5y)19.48%
ROIC(3y)10.49%
ROIC(5y)12.54%
CML.MI Yearly ROA, ROE, ROICCML.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

CML has a better Profit Margin (6.97%) than 86.54% of its industry peers.
In the last couple of years the Profit Margin of CML has grown nicely.
With an excellent Operating Margin value of 14.12%, CML belongs to the best of the industry, outperforming 90.38% of the companies in the same industry.
In the last couple of years the Operating Margin of CML has grown nicely.
Looking at the Gross Margin, with a value of 44.47%, CML is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
CML's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.12%
PM (TTM) 6.97%
GM 44.47%
OM growth 3Y5.5%
OM growth 5Y21.44%
PM growth 3Y7.89%
PM growth 5Y26.25%
GM growth 3Y9.58%
GM growth 5Y17.09%
CML.MI Yearly Profit, Operating, Gross MarginsCML.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CML is creating value.
The number of shares outstanding for CML remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CML has more shares outstanding
CML has a better debt/assets ratio than last year.
CML.MI Yearly Shares OutstandingCML.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CML.MI Yearly Total Debt VS Total AssetsCML.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 0.75, we must say that CML is in the distress zone and has some risk of bankruptcy.
CML's Altman-Z score of 0.75 is on the low side compared to the rest of the industry. CML is outperformed by 69.23% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that CML is somewhat dependend on debt financing.
CML has a Debt to Equity ratio (0.67) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 0.75
ROIC/WACC2.02
WACC7.2%
CML.MI Yearly LT Debt VS Equity VS FCFCML.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

A Current Ratio of 1.11 indicates that CML should not have too much problems paying its short term obligations.
The Current ratio of CML (1.11) is worse than 71.15% of its industry peers.
CML has a Quick Ratio of 1.11. This is a bad value and indicates that CML is not financially healthy enough and could expect problems in meeting its short term obligations.
CML has a worse Quick ratio (0.36) than 96.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.36
CML.MI Yearly Current Assets VS Current LiabilitesCML.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.54% over the past year.
Measured over the past years, CML shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.98% on average per year.
Looking at the last year, CML shows a decrease in Revenue. The Revenue has decreased by -3.02% in the last year.
Measured over the past years, CML shows a very strong growth in Revenue. The Revenue has been growing by 23.83% on average per year.
EPS 1Y (TTM)22.54%
EPS 3Y51.97%
EPS 5Y55.98%
EPS Q2Q%-0.7%
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y41.46%
Revenue growth 5Y23.83%
Sales Q2Q%-13.6%

3.2 Future

Based on estimates for the next years, CML will show a very strong growth in Earnings Per Share. The EPS will grow by 21.72% on average per year.
Based on estimates for the next years, CML will show a very strong growth in Revenue. The Revenue will grow by 35.30% on average per year.
EPS Next Y13.96%
EPS Next 2Y21.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year99.15%
Revenue Next 2Y51.57%
Revenue Next 3Y54.8%
Revenue Next 5Y35.3%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CML.MI Yearly Revenue VS EstimatesCML.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
CML.MI Yearly EPS VS EstimatesCML.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 0.1 0.2 0.3 0.4 0.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.51, which indicates a correct valuation of CML.
Based on the Price/Earnings ratio, CML is valued cheaper than 80.77% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.42. CML is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 12.57, the valuation of CML can be described as correct.
75.00% of the companies in the same industry are more expensive than CML, based on the Price/Forward Earnings ratio.
CML is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.51
Fwd PE 12.57
CML.MI Price Earnings VS Forward Price EarningsCML.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CML is valued a bit cheaper than 67.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.21
CML.MI Per share dataCML.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

CML's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CML has a very decent profitability rating, which may justify a higher PE ratio.
CML's earnings are expected to grow with 21.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.04
PEG (5Y)0.26
EPS Next 2Y21.72%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CML!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMAL SPA

BIT:CML (3/17/2025, 7:00:00 PM)

5.08

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.11%
Inst Owner ChangeN/A
Ins Owners15.28%
Ins Owner ChangeN/A
Market Cap66.50M
Analysts80
Price Target5.81 (14.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.51
Fwd PE 12.57
P/S 1.12
P/FCF N/A
P/OCF N/A
P/B 3.35
P/tB 3.98
EV/EBITDA 9.21
EPS(TTM)0.35
EY6.89%
EPS(NY)0.4
Fwd EY7.95%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS4.53
BVpS1.52
TBVpS1.28
PEG (NY)1.04
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA 1.83%
ROE 20.81%
ROCE 23.62%
ROIC 14.56%
ROICexc 27.65%
ROICexgc 32.88%
OM 14.12%
PM (TTM) 6.97%
GM 44.47%
FCFM N/A
ROA(3y)2.62%
ROA(5y)2.89%
ROE(3y)17.19%
ROE(5y)19.48%
ROIC(3y)10.49%
ROIC(5y)12.54%
ROICexc(3y)16.97%
ROICexc(5y)17.84%
ROICexgc(3y)19.48%
ROICexgc(5y)20.06%
ROCE(3y)16.74%
ROCE(5y)19.7%
ROICexcg growth 3Y20.75%
ROICexcg growth 5Y17.56%
ROICexc growth 3Y20.8%
ROICexc growth 5Y14.05%
OM growth 3Y5.5%
OM growth 5Y21.44%
PM growth 3Y7.89%
PM growth 5Y26.25%
GM growth 3Y9.58%
GM growth 5Y17.09%
F-Score3
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 1.34
Cap/Depr 265.47%
Cap/Sales 7.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.36
Altman-Z 0.75
F-Score3
WACC7.2%
ROIC/WACC2.02
Cap/Depr(3y)308.58%
Cap/Depr(5y)270.84%
Cap/Sales(3y)7.68%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.54%
EPS 3Y51.97%
EPS 5Y55.98%
EPS Q2Q%-0.7%
EPS Next Y13.96%
EPS Next 2Y21.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y41.46%
Revenue growth 5Y23.83%
Sales Q2Q%-13.6%
Revenue Next Year99.15%
Revenue Next 2Y51.57%
Revenue Next 3Y54.8%
Revenue Next 5Y35.3%
EBIT growth 1Y45.55%
EBIT growth 3Y49.24%
EBIT growth 5Y50.39%
EBIT Next Year81.84%
EBIT Next 3Y44.34%
EBIT Next 5Y31.71%
FCF growth 1Y23.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.82%
OCF growth 3YN/A
OCF growth 5YN/A